Pharmacy interventions can reduce
clinical errors - Part I of findings from ISMP survey
Click here for printer friendly version
From the June 26, 2002 issue
In May, over 600 pharmacists responded to an ISMP survey on
pharmacy interventions to tell us about their experiences with:
1) factors that impede or facilitate pharmacy interventions;
2) the types of interventions currently performed; and 3) how
the information is received by physicians, documented and used.
While our survey findings suggest that clinical interventions
are firmly rooted in the way pharmacy services are provided,
the data also tell a story of barriers to optimizing such a
powerful medication safety strategy. When these barriers interfere
with the pharmacist's ability to perform interventions, serious
errors may reach the patient. For example, we recently heard
about an error that could have been avoided if pharmacy interventions
had included verification that only diabetic patients receive
hypoglycemic medications.
A 79-year-old hospitalized woman accidentally received seven
doses of the oral hypoglycemic, glyburide, which was intended
for another patient. A nurse took a verbal order for glyburide
10 mg orally BID for a diabetic patient and correctly transcribed
it onto an order form. But the order form was stamped using
an addressograph plate for the 79-year-old woman, not the
intended patient. Pharmacy received a copy of the order and
dispensed the medication. Because the 79-year-old woman was
not diabetic, she eventually developed symptoms of hypoglycemia
necessitating transfer to ICU. At that time, her blood glucose
level was 10 mg/dL. Fortunately, the patient recovered without
permanent harm.
To prevent such errors, some pharmacies forbid dispensing
insulin or oral hypoglycemic drugs unless the pharmacist confirms
that the patient has diabetes, is on TPN and not tolerating
the glucose load, or has some other therapeutic reason for
the medication. But here's the catch. If there's no reliable
way to obtain this information in a timely manner through
routine mechanisms, the pharmacist must specifically
seek out this information and intervene if the therapy
does not appear to be indicated. While clinical activities
such as this can help lay the foundation for safe medication
therapy, our survey findings suggest that pharmacists face
serious barriers when attempting to perform this service or
level of care.
In our survey, lack of technology support, inadequate staffing,
and an inefficient documentation process were cited as the
most frequent barriers to pharmacy interventions. (See page
three for a table with results related to the barriers and
facilitators of pharmacy interventions.) Regardless of hospital
size, only about a quarter of respondents felt that proper
technology was in place to aid clinical decision-making. Just
16% of all respondents felt they had adequate staffing levels
to carry out pharmacy interventions. Hospitals with less than
100 beds reported the least problems with staffing adequacy
to perform interventions. Only 30% of all respondents felt
that pharmacists had sufficient clinical intervention skills,
but specialty hospitals and hospitals with pharmacy residency
programs reported a higher level of satisfaction with the
clinical skills of pharmacists than general hospitals or hospitals
without pharmacy residency programs.
Overall, just 31% of respondents reported that pharmacists
were highly motivated to perform interventions. Interestingly,
hospitals without physician or pharmacy residency programs
reported a higher level of staff motivation for intervention
activities than hospitals with training programs. Likewise,
specialty hospitals and smaller hospitals under 300 beds reported
considerably higher levels of motivation to perform interventions
than general hospitals and larger hospitals over 300 beds
(as much as a 29% difference). Specialty hospitals also reported
higher satisfaction with staffing levels and pharmacists'
skills. Little difference was noted between hospitals of varying
type, size, or training programs on the issue of supportive
leadership and culture, with just 32% of all pharmacists reporting
that such factors are present to facilitate clinical pharmacy
interventions in their hospitals.
The least likely barrier to pharmacy interventions was lack
of access to information, with 70% of all respondents reporting
easy access to drug information and 55% reporting easy access
to patient information. Hospitals with physician and pharmacy
training programs reported easier access to drug information
than hospitals without training programs. The largest hospitals
reported the lowest satisfaction with access to patient information.
Despite these barriers, our survey findings also clearly
show that pharmacy interventions have a strong foothold in
healthcare and are well received by the medical staff as a
whole. In our next issue, we will discuss the findings related
to the types of clinical pharmacy intervention services currently
performed in hospitals and how the information is documented
and used to reduce the risk of error.
Pharmacy interventions - Part II
from ISMP survey
From the July 10, 2002 issue
In May, more than 600 pharmacists responded to an ISMP survey
on pharmacy interventions. In our last issue, we reported the
findings related to factors that impede or facilitate interventions.
As noted in Part I of our survey findings, respondents frequently
reported barriers to pharmacy interventions (e.g., inadequate
technology support, staffing, clinical skills, motivation, culture,
etc.). Yet, despite these barriers, our survey findings clearly
show that both targeted and routine pharmacy interventions occur
regularly in hospitals, that they have been well accepted by
most medical staffs, and that interventions have been used,
at least to some degree, to reduce the risk of medication errors.
Intervention types: According to respondents, the
most common routine interventions performed in the pharmacy
included assuring orders were complete (89%), allergy checking
(87%), and dose verification (86%). Targeted pharmacy interventions
performed in patient care units were reported less frequently,
with the most common categories including antimicrobial therapy
(31%), renal dosing (30%), and monitoring of special populations
such as pediatrics (29%). Larger hospitals and hospitals with
physician and pharmacy training programs were more likely
to perform these targeted interventions. Overall, the least
common categories for interventions included anticoagulation
and narcotics/pain control.
Communication: Half of all respondents communicated
at least 80% of interventions directly to prescribers, and
about a third of all respondents said that pharmacists communicated
interventions directly to prescribers more than 90% of the
time. Hospitals with physician training programs were more
likely to communicate interventions directly to physicians.
About 19% reported that all interventions were communicated
directly to prescribers vs. 7% in hospitals without training,
and 40% reported that most (90%) interventions were reported
directly to prescribers vs. 23% in hospitals without training.
Physician acceptance: Ninety four percent of respondents
felt that the medical staff, as a whole, responded well to
pharmacists' interventions. In fact, about a third reported
that physicians accepted more than 95% of recommendations,
and only 10% reported that physicians accepted less than 80%
of pharmacy recommendations. Hospitals with physician or pharmacy
training programs reported even higher levels of medical staff
acceptance of interventions. Little difference was noted between
hospitals of varying size or type.
Documentation: About three-quarters of respondents
documented pharmacy interventions, and of those, only 61%
felt that it was detailed enough to guide improvement. Larger
hospitals documented interventions more frequently than hospitals
under 100 beds. Paper (33%) and the pharmacy computer (44%)
were the most common vehicles for documenting the interventions.
Only 3% of hospitals use Personal Digital Assistants (PDAs).
Use of interventions: Just two thirds of respondents
reported that pharmacy interventions had been presented to
committees/staff for the purpose of improving the prescribing
process. Even less (44%) used pharmacy interventions to plan
and carry out medical staff education. Likewise, only two
thirds of hospitals reported using pharmacy interventions
to improve the prescribing process in the past year. Hospitals
with more than 100 beds and those with physician training
programs used intervention information more often to improve
the prescribing process than hospitals with 100 beds or less
and those without physician training programs. Likewise, larger
hospitals and those with pharmacy and physician training programs
provided prescriber education based on information learned
from interventions more frequently than smaller hospitals
and those without training programs.
Evaluation of pharmacists' performance: Less than half
of all respondents reported using interventions as a measure
of performance when evaluating pharmacists. Hospitals over 500
beds and those with pharmacy and physician training programs
reported using interventions as a performance measure more frequently
than smaller hospitals and those without training programs.
Overall, our survey findings clearly suggest that vital,
clinical pharmacy activities occur everyday in hospitals.
Yet hospitals of all types, sizes, and teaching affiliations
are struggling in some way to perform pharmacy interventions
effectively and use the information to improve the prescribing
process and reduce the risk of errors. For example, while
smaller hospitals reported fewer barriers to performing interventions,
they also reported less success using the information to provide
educational programs and improve the prescribing the process.
While hospitals without training programs reported higher
staff motivation to perform interventions, they were less
likely to perform some of the more targeted, clinical interventions.
While larger hospitals were able to use intervention information
more frequently to improve the prescribing process, they also
reported the most significant barriers to accessing crucial
patient information. Regardless of size, type, or teaching
affiliation, one thing stands out clearly - hospitals are
missing out on a virtual gold mine of information that can
lead to reduced errors. Take the time to review your pharmacy
intervention program and maximize its capacity to reduce medication
errors. The complete two-part series on pharmacy interventions
and associated tables with findings appear on our web site.
|
|